Cytokinetics
Clinical trials sponsored by Cytokinetics, explained in plain language.
-
Heart drug aficamten under Long-Term safety watch
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called aficamten for people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens. About 900 adults who have already taken aficamten in earlier studies will continue taking it and be monitored for si…
Phase: PHASE2, PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug could help people with stiff heart muscle breathe easier
Disease control OngoingThis study tests a new medicine called aficamten in 500 adults with a type of heart muscle disease that makes the heart stiff and hard to fill with blood. The goal is to see if the drug improves quality of life and exercise ability compared to a placebo. Participants take the dru…
Phase: PHASE3 • Sponsor: Cytokinetics • Aim: Disease control
Last updated May 13, 2026 16:01 UTC